LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study

Post time 2024-4-24 09:48:40

journal：Annals of Oncology

Authors：S. Lu; J. Wu; J. Jiang; Q. Guo; Y. Yu; Y. Liu; H. Zhang; L. Qian; X. Dai; Y. Xie; T. Fu; T. Lee; Y. Lu; R. Ma; M. Eisner

Published date：2023-10-

DOI：10.1016/j.annonc.2023.10.099

PDF link：https://www.sciencedirect.com/sc ... 923753423042631/pdf

Article link：http://dx.doi.org/10.1016/j.annonc.2023.10.099

Article Source：Elsevier BV。

Remark：

Post time 2024-4-24 09:48:41

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study